Article 52-10-11Depreciable Assets under Article 349-3, Paragraph (31) of the Act
第五十二条の十の十一(法第三百四十九条の三第三十一項の償却資産)
The depreciable assets specified by Cabinet Order as prescribed in Article 349-3, paragraph (31) of the Act are depreciable assets (excluding those used for offices or housing) used for those services, among the services prescribed in Article 16, item (i) or (ii) of the Act on the Japan Agency for Medical Research and Development, National Research and Development Agency (Act No. 49 of 2014), that are listed below and specified by Order of the Ministry of Internal Affairs and Communications.
法第三百四十九条の三第三十一項に規定する政令で定める償却資産は、国立研究開発法人日本医療研究開発機構法(平成二十六年法律第四十九号)第十六条第一号又は第二号に規定する業務のうち次に掲げるもので総務省令で定めるものの用に供する償却資産(事務所又は宿舎の用に供するものを除く。)とする。
Services relating to basic research in the medical field or foundational research and development in the medical field (meaning common research and development in the medical field, or comprehensive research and development in the medical field requiring the cooperation of many sectors);
医療分野の基礎研究又は医療分野の基盤的研究開発(医療分野の共通的な研究開発又は医療分野の研究開発であつて多数部門の協力を要する総合的なものをいう。)に係る業務
Services relating to clinical trials or clinical research (limited to those conducted with the costs of their implementation being funded or subsidized by the State);
治験又は臨床研究に係る業務(その実施に要する費用について国から出資又は補助を受けて行われるものに限る。)
In addition to those listed in the preceding two items, research and development in the medical field relating to technologies whose commercialization is difficult (limited to that conducted with the whole of the costs required for its implementation being funded or subsidized by the State).
前二号に掲げるもののほか、企業化が困難な技術に関する医療分野の研究開発(その実施に要する費用の全額について国から出資又は補助を受けて行われるものに限る。)
Read this with the articles around it